A groundbreaking study conducted by researchers at Mass General Brigham and the Richard A. and Susan F. Smith Center for Outcomes Research at Beth Israel Deaconess Medical Center has provided critical insights into the changes in patient healthcare expenditures following the enactment of the No Surprises Act in 2022. This landmark bipartisan legislation was designed to eliminate unexpected billing shocks that occur when patients unknowingly receive care from out-of-network providers. The team’s comprehensive analysis reveals that the law has successfully lowered out-of-pocket expenses, saving patients nearly $600 annually on average, signaling a significant step toward mitigating financial burdens in healthcare.
Prior to the law’s implementation, unpredictable and exorbitant surprise medical bills affected roughly one in every five insured adults in the United States. These unexpected charges often soared into the thousands of dollars, posing severe financial hardships. Dr. Michael Liu, the study’s lead author and a clinical fellow at Brigham and Women’s Hospital, emphasized the importance of rigorous assessment to quantify the real-world impact of this complex legislation. The study stands out as the first rigorous empirical evaluation measuring the financial consequences for patients directly attributable to the No Surprises Act.
The investigation drew upon extensive claims data encompassing 17,351 adults aged 19 to 64 who held direct-purchase private insurance plans. The research design capitalized on a natural experiment by comparing outcomes between individuals residing in states newly protected by the federal law and those in states that had already enacted similar surprise billing restrictions prior to the No Surprises Act. This comparative approach allowed the investigators to isolate the federal law’s effect from preexisting state regulations, thereby providing a nuanced understanding of policy impact.
Quantitative data analysis revealed a marked reduction in out-of-pocket medical spending among patients in intervention states, amounting to nearly $600 in annual savings per patient. This outstanding achievement underscores the law’s potential for shielding citizens from unpredictable financial shocks related to emergency or ancillary medical services rendered out-of-network. Conversely, patients in control states where protective laws predated the federal statute did not experience comparable declines, reinforcing the causal link.
An intriguing yet concerning finding from the study pertains to insurance premium costs. Despite predictions that the No Surprises Act would facilitate more equitable payment negotiations between healthcare providers and insurers—potentially reducing insurance premiums—data showed no significant change in monthly premium amounts post-implementation. Dr. Liu suggested that this stagnancy might stem from strategic maneuvers by some providers, particularly those affiliated with private equity firms, who may be exploiting legal ambiguities and leveraging unfair practices to maintain or increase reimbursement levels.
Beyond average spending reductions, the study delved into the persistent issue of high financial burden, defined as families spending more than 10% of their income on healthcare expenses. This segment of the population saw negligible improvement after the law’s enactment, highlighting the limits of current policy measures. Financial toxicity remains a formidable barrier to equitable healthcare access, especially among socioeconomically disadvantaged populations. The findings advocate for ongoing policy innovation aimed at substantially alleviating these disproportionate burdens.
This research holds wide-ranging implications for healthcare practitioners, policymakers, and patient advocacy groups committed to combating the escalating problem of medical financial toxicity. By empirically demonstrating tangible patient savings while revealing the persistence of cost challenges, the study offers evidence-based guidance for framing future legislative and regulatory reforms designed to enhance affordability without compromising care quality.
Notably, the investigative team’s robust analytical methodology relied on sophisticated data and statistical techniques to parse claims records accurately. This rigorous approach entailed distinguishing between baseline spending trends, state-level policy heterogeneity, and federal law effects. The triangulation of these factors afforded a comprehensive understanding of the interplay between legislation and financial outcomes in healthcare markets.
The No Surprises Act specifically prohibits surprise bills from out-of-network emergency services and certain non-emergency services at in-network facilities, representing a systemic effort to curb opportunistic billing practices. Ensuring patient protection under this framework demands persistent vigilance as providers and insurers adjust to new regulatory landscapes. This study serves as a critical early evaluation, but continuous monitoring is required to measure long-term consequences on the broader healthcare economy.
Senior author Dr. Rishi Wadhera emphasized that while the No Surprises Act constitutes a milestone in patient financial protection, it should be viewed as part of a larger strategy to resolve the U.S. healthcare affordability crisis. He advocates for multipronged policy solutions addressing wider cost drivers, including pharmaceutical pricing, insurance design, and health system consolidation effects, which continue to challenge equitable access.
The study’s authorship includes key contributors from Mass General Brigham, notably Kushal Kadakia alongside Drs. Liu and Wadhera, highlighting the multidisciplinary collaboration essential for addressing multifaceted health economics issues. Their disclosures affirm transparency, revealing financial relationships and grant support that contextualize the research integrity. Funding sourced from institutions such as the National Heart, Lung, and Blood Institute and the American Heart Association underscores the broader recognition of this work’s significance.
Published in the prestigious British Medical Journal (BMJ), this landmark paper titled “Patient Healthcare Spending After the No Surprises Act” presents a decisive addition to the growing body of literature exploring the intersections of health policy, economics, and patient welfare. Its findings will likely catalyze further investigations and policy dialogues, aiming to build upon the Act’s achievements while rectifying its shortcomings.
In an era where healthcare costs constitute a major concern for millions of Americans, this study provides a beacon of hope that federal legislation can bring measurable financial relief. At the same time, it exhorts stakeholders to remain proactive in tackling persistent gaps to reduce healthcare-related financial strain comprehensively. Through ongoing research, advocacy, and policy refinement, the ambition of affordable, transparent healthcare billing edges closer to reality.
Subject of Research: People
Article Title: Patient Healthcare Spending After the No Surprises Act
News Publication Date: 27-Aug-2025
Web References:
- https://www.massgeneralbrigham.org/
- https://www.bmj.com/content/390/bmj-2025-084803
- http://dx.doi.org/10.1136/bmj-2025-084803
References:
Liu M et al. “Patient Healthcare Spending After the No Surprises Act” BMJ DOI: 10.1136/bmj-2025-084803
Keywords: Health care, Medical economics
